Annual Total Assets
$165.32 M
-$397.19 M-70.61%
31 December 2023
Summary:
Sangamo Therapeutics annual total assets is currently $165.32 million, with the most recent change of -$397.19 million (-70.61%) on 31 December 2023. During the last 3 years, it has fallen by -$773.23 million (-82.39%). SGMO annual total assets is now -82.39% below its all-time high of $938.55 million, reached on 31 December 2020.SGMO Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$111.26 M
+$18.25 M+19.62%
30 September 2024
Summary:
Sangamo Therapeutics quarterly total assets is currently $111.26 million, with the most recent change of +$18.25 million (+19.62%) on 30 September 2024. Over the past year, it has dropped by -$108.43 million (-49.36%). SGMO quarterly total assets is now -88.45% below its all-time high of $963.71 million, reached on 30 September 2020.SGMO Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGMO Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -70.6% | -49.4% |
| 3 y3 years | -82.4% | -85.6% |
| 5 y5 years | -72.0% | -82.6% |
SGMO Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -82.4% | at low | -85.6% | +19.6% |
| 5 y | 5 years | -82.4% | at low | -88.5% | +19.6% |
| alltime | all time | -82.4% | >+9999.0% | -88.5% | +384.8% |
Sangamo Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $111.26 M(+19.6%) |
| June 2024 | - | $93.01 M(-27.9%) |
| Mar 2024 | - | $128.96 M(-22.0%) |
| Dec 2023 | $165.32 M(-70.6%) | $165.32 M(-24.8%) |
| Sept 2023 | - | $219.70 M(-32.4%) |
| June 2023 | - | $325.07 M(-26.2%) |
| Mar 2023 | - | $440.57 M(-21.7%) |
| Dec 2022 | $562.51 M(-22.1%) | $562.51 M(-5.3%) |
| Sept 2022 | - | $593.91 M(-3.8%) |
| June 2022 | - | $617.13 M(-5.7%) |
| Mar 2022 | - | $654.31 M(-9.4%) |
| Dec 2021 | $721.92 M(-23.1%) | $721.92 M(-6.5%) |
| Sept 2021 | - | $772.40 M(-7.5%) |
| June 2021 | - | $835.36 M(-4.8%) |
| Mar 2021 | - | $877.10 M(-6.5%) |
| Dec 2020 | $938.55 M(+47.2%) | $938.55 M(-2.6%) |
| Sept 2020 | - | $963.71 M(+7.7%) |
| June 2020 | - | $894.66 M(+53.1%) |
| Mar 2020 | - | $584.28 M(-8.4%) |
| Dec 2019 | $637.52 M(+8.0%) | $637.52 M(-0.4%) |
| Sept 2019 | - | $640.22 M(-4.9%) |
| June 2019 | - | $673.48 M(+24.1%) |
| Mar 2019 | - | $542.73 M(-8.1%) |
| Dec 2018 | $590.39 M(+105.9%) | $590.39 M(-2.7%) |
| Sept 2018 | - | $606.60 M(-3.4%) |
| June 2018 | - | $627.73 M(+123.3%) |
| Mar 2018 | - | $281.17 M(-1.9%) |
| Dec 2017 | $286.74 M(+81.6%) | $286.74 M(+6.3%) |
| Sept 2017 | - | $269.79 M(-4.7%) |
| June 2017 | - | $282.99 M(+92.8%) |
| Mar 2017 | - | $146.81 M(-7.0%) |
| Dec 2016 | $157.89 M(-27.3%) | $157.89 M(-4.3%) |
| Sept 2016 | - | $164.98 M(-8.8%) |
| June 2016 | - | $180.91 M(-8.2%) |
| Mar 2016 | - | $197.05 M(-9.3%) |
| Dec 2015 | $217.24 M(-10.7%) | $217.24 M(-6.6%) |
| Sept 2015 | - | $232.52 M(+1.1%) |
| June 2015 | - | $229.95 M(-3.6%) |
| Mar 2015 | - | $238.50 M(-1.9%) |
| Dec 2014 | $243.21 M(+72.7%) | $243.21 M(-1.7%) |
| Sept 2014 | - | $247.35 M(-1.4%) |
| June 2014 | - | $250.84 M(-1.8%) |
| Mar 2014 | - | $255.50 M(+81.4%) |
| Dec 2013 | $140.84 M(+70.6%) | $140.84 M(+0.3%) |
| Sept 2013 | - | $140.37 M(+89.2%) |
| June 2013 | - | $74.20 M(-2.2%) |
| Mar 2013 | - | $75.84 M(-8.1%) |
| Dec 2012 | $82.53 M(-5.5%) | $82.53 M(+0.9%) |
| Sept 2012 | - | $81.81 M(-5.2%) |
| June 2012 | - | $86.31 M(-4.5%) |
| Mar 2012 | - | $90.42 M(+3.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $87.34 M(+38.6%) | $87.34 M(-1.1%) |
| Sept 2011 | - | $88.31 M(-7.6%) |
| June 2011 | - | $95.62 M(+82.0%) |
| Mar 2011 | - | $52.54 M(-16.6%) |
| Dec 2010 | $63.00 M(-28.0%) | $63.00 M(-4.4%) |
| Sept 2010 | - | $65.89 M(-8.6%) |
| June 2010 | - | $72.11 M(-9.1%) |
| Mar 2010 | - | $79.36 M(-9.2%) |
| Dec 2009 | $87.44 M(+28.9%) | $87.44 M(+70.2%) |
| Sept 2009 | - | $51.38 M(-6.5%) |
| June 2009 | - | $54.94 M(-9.8%) |
| Mar 2009 | - | $60.88 M(-10.3%) |
| Dec 2008 | $67.85 M(-19.1%) | $67.85 M(-4.1%) |
| Sept 2008 | - | $70.75 M(-6.8%) |
| June 2008 | - | $75.93 M(-1.1%) |
| Mar 2008 | - | $76.74 M(-8.5%) |
| Dec 2007 | $83.90 M(+50.4%) | $83.90 M(-2.8%) |
| Sept 2007 | - | $86.34 M(+84.0%) |
| June 2007 | - | $46.94 M(-7.1%) |
| Mar 2007 | - | $50.55 M(-9.4%) |
| Dec 2006 | $55.78 M(+13.9%) | $55.78 M(-4.3%) |
| Sept 2006 | - | $58.30 M(-4.1%) |
| June 2006 | - | $60.80 M(+38.0%) |
| Mar 2006 | - | $44.05 M(-10.1%) |
| Dec 2005 | $48.98 M(+41.1%) | $48.98 M(+98.7%) |
| Sept 2005 | - | $24.65 M(-9.9%) |
| June 2005 | - | $27.35 M(-11.3%) |
| Mar 2005 | - | $30.82 M(-11.3%) |
| Dec 2004 | $34.73 M(-24.9%) | $34.73 M(-4.5%) |
| Sept 2004 | - | $36.36 M(-9.9%) |
| June 2004 | - | $40.36 M(-6.7%) |
| Mar 2004 | - | $43.27 M(-6.4%) |
| Dec 2003 | $46.23 M(-17.8%) | $46.23 M(-3.9%) |
| Sept 2003 | - | $48.10 M(-3.9%) |
| June 2003 | - | $50.05 M(-5.1%) |
| Mar 2003 | - | $52.72 M(-6.2%) |
| Dec 2002 | $56.23 M(-33.9%) | $56.23 M(+0.4%) |
| Sept 2002 | - | $56.03 M(-27.4%) |
| June 2002 | - | $77.20 M(-4.4%) |
| Mar 2002 | - | $80.72 M(-5.1%) |
| Dec 2001 | $85.02 M(+23.3%) | $85.02 M(-2.2%) |
| Sept 2001 | - | $86.90 M(+32.7%) |
| June 2001 | - | $65.50 M(-3.6%) |
| Mar 2001 | - | $67.94 M(-1.4%) |
| Dec 2000 | $68.92 M(+649.2%) | $68.92 M(-0.2%) |
| Sept 2000 | - | $69.06 M(-1.1%) |
| June 2000 | - | $69.79 M(+204.1%) |
| Mar 2000 | - | $22.95 M |
| Dec 1999 | $9.20 M(+128.2%) | - |
| Dec 1998 | $4.03 M(-41.5%) | - |
| Dec 1997 | $6.90 M(+1179.4%) | - |
| Dec 1996 | $539.00 K | - |
FAQ
- What is Sangamo Therapeutics annual total assets?
- What is the all time high annual total assets for Sangamo Therapeutics?
- What is Sangamo Therapeutics annual total assets year-on-year change?
- What is Sangamo Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Sangamo Therapeutics?
- What is Sangamo Therapeutics quarterly total assets year-on-year change?
What is Sangamo Therapeutics annual total assets?
The current annual total assets of SGMO is $165.32 M
What is the all time high annual total assets for Sangamo Therapeutics?
Sangamo Therapeutics all-time high annual total assets is $938.55 M
What is Sangamo Therapeutics annual total assets year-on-year change?
Over the past year, SGMO annual total assets has changed by -$397.19 M (-70.61%)
What is Sangamo Therapeutics quarterly total assets?
The current quarterly total assets of SGMO is $111.26 M
What is the all time high quarterly total assets for Sangamo Therapeutics?
Sangamo Therapeutics all-time high quarterly total assets is $963.71 M
What is Sangamo Therapeutics quarterly total assets year-on-year change?
Over the past year, SGMO quarterly total assets has changed by -$108.43 M (-49.36%)